• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 3. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Quinazolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Benzodiazines Quinazolines

Introduction to 6-Methoxyquinazoline (CAS No. 7556-92-5)

6-Methoxyquinazoline, identified by the Chemical Abstracts Service Number (CAS No.) 7556-92-5, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry due to its versatile structural framework and potential biological activities. As a derivative of the quinazoline scaffold, this compound exhibits unique chemical and pharmacological properties that make it a valuable intermediate in the synthesis of various therapeutic agents.

The molecular structure of 6-Methoxyquinazoline consists of a six-membered aromatic ring system fused with a nitrogen-containing ring, with a methoxy group (-OCH?) substituent at the 6-position. This structural motif is known to contribute to its interactions with biological targets, particularly enzymes and receptors involved in critical cellular processes. The presence of the methoxy group enhances its solubility in polar solvents, facilitating its use in both in vitro and in vivo experimental settings.

In recent years, 6-Methoxyquinazoline has been extensively studied for its role as a key intermediate in the development of novel pharmaceuticals. One of the most promising applications of this compound is in the synthesis of kinase inhibitors, which are widely used to treat cancers and inflammatory diseases. The quinazoline core is a well-documented pharmacophore in drug discovery, with several FDA-approved drugs featuring this scaffold. For instance, 6-Methoxyquinazoline derivatives have been investigated for their potential to modulate tyrosine kinases, which play a crucial role in cell signaling pathways associated with tumor growth and progression.

Recent advancements in computational chemistry have enabled more efficient virtual screening of compounds like 6-Methoxyquinazoline for their binding affinity to specific biological targets. Molecular docking studies have revealed that certain derivatives of this compound exhibit high selectivity for particular kinases, such as EGFR (epidermal growth factor receptor) and JAK (Janus kinase), making them promising candidates for further development into targeted therapies. These findings align with the broader trend toward precision medicine, where drugs are tailored to interact specifically with disease-causing proteins.

The synthesis of 6-Methoxyquinazoline typically involves multi-step organic reactions, often starting from readily available precursors such as anthranilic acid or 2-amino-4-methylquinazole. The methoxylation step at the 6-position can be achieved using various methylating agents under controlled conditions to ensure regioselectivity and high yield. Advances in green chemistry have also led to the development of more sustainable synthetic routes, employing catalytic methods that minimize waste and energy consumption.

Beyond its applications in oncology, 6-Methoxyquinazoline has shown potential in other therapeutic areas. For example, studies have demonstrated its ability to inhibit certain bacterial enzymes, suggesting its utility in developing novel antibiotics or antimicrobial agents. The quinazoline scaffold is known for its broad spectrum of activity against pathogens, making it an attractive candidate for addressing antibiotic resistance.

The pharmacokinetic properties of 6-Methoxyquinazoline are also an area of active research. Understanding how this compound is metabolized and eliminated from the body is crucial for optimizing its therapeutic efficacy and minimizing potential side effects. Preclinical studies using animal models have provided insights into its absorption, distribution, metabolism, and excretion (ADME) profiles, which are essential data points for regulatory submissions and clinical trials.

As interest in natural product-inspired drug design grows, researchers have explored bioisosteric analogs of 6-Methoxyquinazoline, incorporating elements from plant-derived compounds while maintaining similar biological activity. These efforts aim to leverage nature's chemical diversity while ensuring synthetic feasibility and pharmacological potency. Some preliminary findings suggest that such derivatives retain key pharmacophoric features while offering improved solubility or bioavailability.

The role of 6-Methoxyquinazoline as a building block for more complex molecules cannot be overstated. Its versatility allows chemists to modify various positions on the quinazoline ring or append different functional groups to tailor biological activity toward specific therapeutic goals. This flexibility has led to a surge in patent filings involving derivatives of this compound, highlighting its commercial significance in the pharmaceutical industry.

In conclusion,6-Methoxyquinazoline (CAS No. 7556-92-5) represents a cornerstone compound in modern medicinal chemistry. Its unique structural features and diverse biological applications make it indispensable for drug discovery efforts targeting cancers, inflammatory diseases, and infections. As research continues to uncover new synthetic methods and pharmacological insights,6-Methoxyquinazoline will undoubtedly remain at the forefront of pharmaceutical innovation.

• 88368-29-0(7H-Pyrimido[5,4-c]carbazole, 10-methoxy-)
• 7556-88-9(5-Quinazolinol (7CI,8CI,9CI))
• 7557-01-9(8-Methoxyquinazoline)
• 953039-15-1(2-chloro-7-methoxyquinazoline)
• 7556-97-0(quinazolin-7-ol)
• 7556-87-8(5-Methoxyquinazoline)
• 28825-07-2(1H-Naphth[1,2-d]imidazole,9-methoxy-)
• 850424-11-2(2-Chloro-6-methoxyquinazoline)
• 7556-93-6(quinazolin-6-ol)
• 7557-02-0(Quinazolin-8-ol)